From the publishers of JADPRO
CAR T-Cell Therapy
Resource Center
Menu
Resources
Videos
Videos
Fast Facts
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Fast Facts #8: Current Commerical Products
Last Updated: Monday, January 24, 2022
Test your knowledge on CAR T-cell Products
Last Updated: Monday, January 24, 2022
Loading...
Advertisement
News & Literature Highlights
Transplantation and Cellular Therapy
Neurotoxicity and rare adverse events in BCMA-directed CAR T cell therapy: A comprehensive analysis of real-world FAERS data
Transplantation and Cellular Therapy
Clinical experience with cranial nerve impairment in the CARTITUDE-1, CARTITUDE-2 cohorts A, B, and C, and CARTITUDE-4 studies of ciltacabtagene autoleucel (cilta-cel)
Nature Medicine
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: A phase 1 trial
Blood Advances
Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucel
Blood Advances
Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma
Journal of Clinical Oncology
Comparison of standard-of-care idecabtagene vicleucel and ciltacabtagene autoleucel in relapsed/refractory multiple myeloma
Cancer Cell
Restoration of LAT activity improves CAR T cell sensitivity and persistence in response to antigen-low acute lymphoblastic leukemia
Pediatric Blood & Cancer
Neuropsychological functioning in pediatric patients with leukemia or lymphoma treated with CAR T-cell therapy: A retrospective chart review
Leukemia
Anti-CD19 CAR-T cell therapy for acquired hemophilia A
Brain
Current state and perspectives of CAR T-cell therapy in central nervous system diseases
Advertisement
Case Studies
Bloodless Medicine Management of a Patient Receiving CAR T-Cell Therapy
Transverse Myelitis With Paraplegia: An Atypical Manifestation of Neurotoxicity Following CAR T-Cell Therapy
CAR T-cell Infusion in an Outpatient Setting: An Ideal Option for Selected Patients When Available
Fast Facts
Fast Facts #12: BCMA Targets
Advertisement
Quizzes
Test Your Knowledge of Bloodless Medicine Management of a Patient Receiving CAR T-Cell Therapy
Test your knowledge of atypical manifestation of neurotoxicity following CAR T-cell therapy
Test your knowledge of CAR T-cell therapy